Show simple item record

dc.contributor.authorHe, S.
dc.contributor.authorWang, D.
dc.contributor.authorLu, Y.
dc.contributor.authorChen, Younan
dc.contributor.authorJin, X.
dc.contributor.authorWang, C.
dc.contributor.authorZhao, J.
dc.contributor.authorRen, Y.
dc.contributor.authorWang, L.
dc.contributor.authorLi, H.
dc.contributor.authorCheng, J.
dc.date.accessioned2017-01-30T12:41:43Z
dc.date.available2017-01-30T12:41:43Z
dc.date.created2015-10-29T04:10:13Z
dc.date.issued2013
dc.identifier.citationHe, S. and Wang, D. and Lu, Y. and Chen, Y. and Jin, X. and Wang, C. and Zhao, J. et al. 2013. Increasing glucagon secretion could antagonize the action of exogenous insulin for glycemic control in streptozocin-induced diabetic rhesus monkeys. Experimental Biology and Medicine. 238 (4): pp. 385-391.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/24235
dc.identifier.doi10.1177/1535370213477974
dc.description.abstract

Although intraislet insulin signaling is known to play a critical role in regulating glucagon secretion, it is unknown whether abnormal glucagon secretion influences the hypoglycemic effect of exogenous insulin with intraislet insulin deletion. We performed a longitudinal study using 16 streptozocin (STZ)-induced diabetic rhesus monkeys to explore a-cell function under the absence ß-cells and to assess whether increasing glucagon secretion antagonizes the action of exogenous insulin for glycemic control. We found that although the a-cells were impaired and the basal secretion levels of glucagon decreased rapidly after STZ (80-90 mg/kg) administration, as based on long-term observation post-STZ injection, glucagon secretion and the number of a-cells were increased. Glycemic control was increasingly difficult, the insulin resistance (HOMA-IR) index was significantly higher, and the triglycerides (TG) levels were gradually decreased. Moreover, a significant correlation between the levels of glucagon and HOMA-IR was found. Under the long-term absence of ß-cells, the inhibitory effect on a-cell activity is profoundly attenuated, leading to an increase in glucagon secretion and the amount of a-cells and even a-cell dysfunction. Increased glucagon levels have a serious impact on the insulin sensitivity in vivo and result in an antagonization of the hypoglycemic effect of exogenous insulin. © 2013 by the Society for Experimental Biology and Medicine.

dc.titleIncreasing glucagon secretion could antagonize the action of exogenous insulin for glycemic control in streptozocin-induced diabetic rhesus monkeys
dc.typeJournal Article
dcterms.source.volume238
dcterms.source.number4
dcterms.source.startPage385
dcterms.source.endPage391
dcterms.source.issn1535-3702
dcterms.source.titleExperimental Biology and Medicine
curtin.departmentSchool of Biomedical Sciences
curtin.accessStatusFulltext not available


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record